Six months after a second dose of a Pfizer COVID-19 vaccine, men had substantially lower levels of neutralizing antibodies than women in a study published Oct. 6 in The New England Journal of Medicine.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,